{"filing":{"accession_number":"0000785161-26-000183","cik":"0000785161","ticker":"EHC","company_name":"Encompass Health Corp","form":"8-K","filing_date":"2026-08-05","report_date":"2026-08-05","primary_document":"ehc-20260805.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/785161/000078516126000183/ehc-20260805.htm"},"events":[{"id":24328,"run_id":22032,"accession_number":"0000785161-26-000183","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.97,"summary":"Encompass Health issued a press release on August 5, 2026 reporting Q2 and six-month financial results ended June 30, 2026, including net operating revenue of $1,597.4 million (9.6% growth), adjusted EBITDA of $348.0 million (9.2% growth), adjusted EPS of $1.55, updated full-year 2026 guidance, and announcement of increased stock repurchase authorization.","company_name":"Encompass Health Corp","ticker":"EHC","filing_date":"2026-08-05","form":"8-K","submitted_at":null,"items":[{"id":24839,"accession_number":"0000785161-26-000183","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Encompass Health issued a press release on August 5, 2026 reporting financial results for Q2 and six months ended June 30, 2026, with detailed income statements, balance sheets, and cash flow statements. The disclosure includes revenue growth of 9.6%, adjusted EBITDA growth of 9.2%, updated full-year guidance, and announcement of increased stock repurchase authorization—all hallmarks of a quarterly earnings release under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-06T02:22:38.937251+00:00","company_name":"","ticker":null,"filing_date":""},{"id":24840,"accession_number":"0000785161-26-000183","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Item 7.01 references Item 2.02 (\"Results of Operations and Financial Condition\") and incorporates by reference the earnings press release (Exhibit 99.1) and supplemental information for the earnings call. The press release discloses Q2 2026 financial results showing net operating revenue of $1,597.4 million (9.6% growth), adjusted EBITDA of $348.0 million (9.2% growth), and adjusted EPS of $1.55, along with increased full-year 2026 guidance and a stock repurchase authorization increase. This is a standard quarterly earnings disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-06T02:22:38.937251+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":24839,"accession_number":"0000785161-26-000183","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Encompass Health issued a press release on August 5, 2026 reporting financial results for Q2 and six months ended June 30, 2026, with detailed income statements, balance sheets, and cash flow statements. The disclosure includes revenue growth of 9.6%, adjusted EBITDA growth of 9.2%, updated full-year guidance, and announcement of increased stock repurchase authorization—all hallmarks of a quarterly earnings release under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-06T02:22:38.937251+00:00","company_name":"Encompass Health Corp","ticker":"EHC","filing_date":"2026-08-05"},{"id":24840,"accession_number":"0000785161-26-000183","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Item 7.01 references Item 2.02 (\"Results of Operations and Financial Condition\") and incorporates by reference the earnings press release (Exhibit 99.1) and supplemental information for the earnings call. The press release discloses Q2 2026 financial results showing net operating revenue of $1,597.4 million (9.6% growth), adjusted EBITDA of $348.0 million (9.2% growth), and adjusted EPS of $1.55, along with increased full-year 2026 guidance and a stock repurchase authorization increase. This is a standard quarterly earnings disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-06T02:22:38.937251+00:00","company_name":"Encompass Health Corp","ticker":"EHC","filing_date":"2026-08-05"}]}